Literature DB >> 29562253

Describing Perceived Racial Bias Among Youth With Sickle Cell Disease.

Emily O Wakefield1,2, Ashley Pantaleao3, Jill M Popp4, Lourdes P Dale1, James P Santanelli3, Mark D Litt5, William T Zempsky2.   

Abstract

Objectives: Sickle cell disease (SCD) predominately affects Black Americans. This is the first study of its kind to describe the racial bias experiences of youth with SCD and their reactions to these experiences.
Methods: Participants were 20 youth with SCD (ages 13-21 years) who were asked to describe any racial bias events they experienced, as recorded on the Perception of Racism in Children and Youth measure (PRaCY). Interviews were recorded, transcribed, and analyzed by two independent raters using a conventional content analysis approach.
Results: All participants reported at least one incident of racial bias. Content analysis of racial bias events (n = 104) yielded 4 categories and 12 subcategories as follows: Perpetrator (Peers, Authority Figures, and General Public), Type of Racial Bias (Explicit, Implicit), Behavioral Reaction (Approach, Avoidant), and Emotional Response (Dysphoria, Anger, Unconcerned, Inferior, Anxious). Discussion: This study provides a description of racial bias experiences within community and medical settings and highlights the need for further evaluation of the impact of racial bias among youth with SCD.

Entities:  

Mesh:

Year:  2018        PMID: 29562253     DOI: 10.1093/jpepsy/jsy015

Source DB:  PubMed          Journal:  J Pediatr Psychol        ISSN: 0146-8693


  6 in total

1.  Confronting Racism in Pain Research: A Call to Action.

Authors:  Calia A Morais; Edwin N Aroke; Janelle E Letzen; Claudia M Campbell; Anna M Hood; Mary R Janevic; Vani A Mathur; Ericka N Merriwether; Burel R Goodin; Staja Q Booker; Lisa C Campbell
Journal:  J Pain       Date:  2022-02-26       Impact factor: 5.383

2.  Identifying barriers to evidence-based care for sickle cell disease: results from the Sickle Cell Disease Implementation Consortium cross-sectional survey of healthcare providers in the USA.

Authors:  Matthew P Smeltzer; Kristen E Howell; Marsha Treadwell; Liliana Preiss; Allison A King; Jeffrey A Glassberg; Paula Tanabe; Sherif M Badawy; Lisa DiMartino; Robert Gibson; Julie Kanter; Lisa M Klesges; Jane S Hankins
Journal:  BMJ Open       Date:  2021-11-17       Impact factor: 2.692

3.  ANTXR1 Regulates Erythroid Cell Proliferation and Differentiation through wnt/β-Catenin Signaling Pathway In Vitro and in Hematopoietic Stem Cell.

Authors:  Tingting Jin; Zhaojun Zhang; Yuanyuan Han; Di Li; Juan Liu; Minmin Jiang; Ryo Kurita; Yukio Nakamura; Fangfang Hu; Xiangdong Fang; Shengwen Huang; Zhaolin Sun
Journal:  Dis Markers       Date:  2022-08-27       Impact factor: 3.464

4.  Psychosocial and Clinical Risk Factors Associated with Substance Use in Observational Cohort of Patients with Sickle Cell Disease.

Authors:  J Deanna Wilson; Sophie Lanzkron; Lydia H Pecker; Shawn M Bediako; Dingfen Han; Mary Catherine Beach
Journal:  Subst Use Misuse       Date:  2020-08-07       Impact factor: 2.164

5.  The influence of perceived racial bias and health-related stigma on quality of life among children with sickle cell disease.

Authors:  Anna M Hood; Lori E Crosby; Eva Hanson; Lisa M Shook; Jeffrey D Lebensburger; Avi Madan-Swain; Megan M Miller; Zina Trost
Journal:  Ethn Health       Date:  2020-09-08       Impact factor: 2.732

6.  Perceptions of US Adolescents and Adults With Sickle Cell Disease on Their Quality of Care.

Authors:  Julie Kanter; Robert Gibson; Raymona H Lawrence; Matthew P Smeltzer; Norma L Pugh; Jeffrey Glassberg; Rita V Masese; Allison A King; Cecelia Calhoun; Jane S Hankins; Marsha Treadwell
Journal:  JAMA Netw Open       Date:  2020-05-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.